COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 521: Articles 5201-5210  | Next

COVID-19db linkage maps of cell surface proteins and transcription factors in immune cells
Ramjattun, K., Ma, X., Gao, S.-J., Singh, H., Osmanbeyoglu, H. U.
10.1101/2022.12.14.520411 — Posted: 2022-12-14
2-Thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses
Uemura, K., Nobori, H., Sato, A., Toba, S., Kusakabe, S., Sasaki, M., Tabata, K., Matsuno, K., Maeda, N., Ito, S., Tanaka, M., Anraku, Y., Kita, S., Ishii, M., Kanamitsu, K., Orba, Y., Matsuura, Y., Hall, W. W., Sawa, H., Kida, H., Matsuda, A., Maenaka, K.
10.1101/2022.12.14.520006 — Posted: 2022-12-14
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments
Zhang, E., Nguyen, T. O., Allen, L., Kedzierski, L., Rowntree, L. C., Chang, S. Y., Foo, I. J., Habel, J. R., Zhang, W., Menon, T., Mitchell, J., Leong, R., Bond, K., Williamson, D. A., Christensen, B., Kedzierska, K.
10.1101/2022.12.13.22283434 — Posted: 2022-12-14
Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China
Leung, K., Leung, G. M., Wu, J.
10.1101/2022.12.14.22283460 — Posted: 2022-12-14
COVID-19 Vaccination in Pregnancy: The Impact of Multimorbidity and Smoking Status on Vaccine Hesitancy, a Cohort Study of 25,111 Women in Wales, UK
Mhereeg, M., Jones, H., Kennedy, J., Seaborne, M., Parker, M., Kennedy, N., Akbari, A., Zuccolo, L., Azcoaga-Lorenzo, A., Davies, A., Nirantharakumar, K., Brophy, S.
10.1101/2022.12.12.22283200 — Posted: 2022-12-14
Severe Acute Respiratory Syndrome Coronavirus 2 detection in induced sputum of asthmatic patients using saliva sampling device
Moermans, C., Gerday, S., Bricmont, N., Bonhiver, R., Schleich, F., GUIOT, J., Njock, M.-S., Henket, M., Guissard, F., Paulus, V., Di Valentin, E., Minner, F., Gillet, L., Bureau, F., Louis, R.
10.1101/2022.12.12.22283341 — Posted: 2022-12-14
Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice
Khan, M. S., Kim, E., Huanga, S., Kenniston, T. W., Gambotto, A.
10.1101/2022.12.12.520124 — Posted: 2022-12-14
SARS-CoV-2 vaccine-breakthrough infections (VBIs) by Omicron (B.1.1.529) variant and consequences in structural and functional impact
Abduljaleel, Z., Melebari, S., Dehlawi, S., Kumar S, U., Aziz, S. A., Dannoun, A. I., Malik, S. M., Doss C, G. P.
10.1101/2022.12.12.520021 — Posted: 2022-12-14
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
Vanhulle, E., Doijen, J., Stroobants, J., Provinciael, B., Noppen, S., Schols, D., Stevaert, A., Vermeire, K.
10.1101/2022.12.13.520307 — Posted: 2022-12-13
Mental Health in Ireland During the Covid Pandemic: Evidence from Two Longitudinal Surveys
Madden, D.
10.1101/2022.12.12.22283343 — Posted: 2022-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).